An initiative to advance the joint development of high-value-added products, expand sales in China, Southeast Asia and the direct-to-consumer channel, and establish an overseas production system through a capital and business alliance with Rohto Pharmaceutical Co., Ltd. It also includes increasing sales through cross-selling.